EQUITY RESEARCH MEMO

DeepLook Medical

Generated 5/10/2026

Executive Summary

Conviction (model self-assessment)45/100

DeepLook Medical is a San Francisco-based private company founded in 2018 that develops AI-powered software to enhance medical imaging. The company aims to enable data-driven imaging for accurate, efficient, and personalized care across the entire treatment pathway. Its technology leverages machine learning to improve diagnostic accuracy and workflow efficiency, potentially reducing interpretation time and improving patient outcomes. Currently at an early stage, DeepLook Medical operates in the competitive AI diagnostics space, focusing on software solutions that integrate with existing imaging systems. While specific products and funding details are not disclosed, the company's vision aligns with the growing demand for AI in radiology and pathology.

Upcoming Catalysts (preview)

  • Q4 2026Series A Funding Round60% success
  • Q2 2027First FDA 510(k) Clearance for Lead Product40% success
  • Q3 2026Strategic Partnership with Major Health System50% success
Locked sections
  • · Pipeline Analysis
  • · Competitive Landscape
  • · Catalyst Calendar (full 12-month)
  • · Bull Case
  • · Bear Case
  • · Counterfactual Scenarios
  • · Valuation Notes
  • · SEC Filing Highlights
  • · Insider Activity
  • · Literature Watch
  • · Patent Landscape
  • · Mechanism Cluster Map
  • · Audio Briefing (5 min)